BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7985031)

  • 21. Of mice, men and motor neurons.
    Newbery HJ; Abbott CM
    Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.
    Wong PC; Pardo CA; Borchelt DR; Lee MK; Copeland NG; Jenkins NA; Sisodia SS; Cleveland DW; Price DL
    Neuron; 1995 Jun; 14(6):1105-16. PubMed ID: 7605627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALS: life and death in a bad neighborhood.
    Monk PN; Shaw PJ
    Nat Med; 2006 Aug; 12(8):885-7. PubMed ID: 16892030
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurodegenerative disease. Oxidative stress and motorneuron disease.
    Sendtner M; Thoenen H
    Curr Biol; 1994 Nov; 4(11):1036-9. PubMed ID: 7874490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of free radicals in amyotrophic lateral sclerosis.
    Liu D
    J Mol Neurosci; 1996; 7(3):159-67. PubMed ID: 8906612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superoxide dismutase (glu100-->gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers.
    Calder VL; Domigan NM; George PM; Donaldson IM; Winterbourn CC
    Neurosci Lett; 1995 Apr; 189(3):143-6. PubMed ID: 7624031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transgenic-mouse model of amyotrophic lateral sclerosis.
    Brown RH
    N Engl J Med; 1994 Oct; 331(16):1091-2. PubMed ID: 8090173
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutant CuZn superoxide dismutase in motor neuron disease.
    Gurney ME; Liu R; Althaus JS; Hall ED; Becker DA
    J Inherit Metab Dis; 1998 Aug; 21(5):587-97. PubMed ID: 9728338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel SOD mutant and ALS.
    Orrell R; de Belleroche J; Marklund S; Bowe F; Hallewell R
    Nature; 1995 Apr; 374(6522):504-5. PubMed ID: 7700376
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2.
    Lee M; Hyun DH; Halliwell B; Jenner P
    J Neurochem; 2001 Jul; 78(2):209-20. PubMed ID: 11461956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses.
    Liochev SI; Fridovich I
    Free Radic Biol Med; 2003 Jun; 34(11):1383-9. PubMed ID: 12757848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis.
    Shinder GA; Lacourse MC; Minotti S; Durham HD
    J Biol Chem; 2001 Apr; 276(16):12791-6. PubMed ID: 11278741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
    Estévez AG
    Free Radic Biol Med; 2007 Jul; 43(2):163-4. PubMed ID: 17603926
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathoetiology of motor neuron disease: new insights from genetics and animal models.
    Trounce I; Feeney S; Byrne E
    J Clin Neurosci; 2003 May; 10(3):293-6. PubMed ID: 12763330
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase.
    Ferri A; Gabbianelli R; Casciati A; Paolucci E; Rotilio G; Carrì MT
    J Neurochem; 2000 Aug; 75(2):606-13. PubMed ID: 10899935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models].
    Dupuis L; Muller A; Meininger V; Loeffler JP
    Rev Neurol (Paris); 2004 Jan; 160(1):35-43. PubMed ID: 14978392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse model found for ALS.
    Marx J
    Science; 1994 Jun; 264(5166):1663-4. PubMed ID: 8209242
    [No Abstract]   [Full Text] [Related]  

  • 38. Early activation of antioxidant mechanisms in muscle of mutant Cu/Zn-superoxide dismutase-linked amyotrophic lateral sclerosis mice.
    Jokic N; Di Scala F; Dupuis L; Rene F; Muller A; Gonzalez De Aguilar JL; Loeffler JP
    Ann N Y Acad Sci; 2003 Dec; 1010():552-6. PubMed ID: 15033789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetics of motor neuron disorders].
    Corcia P; Praline J; Vourc'h P; Andres C
    Rev Neurol (Paris); 2008 Feb; 164(2):115-30. PubMed ID: 18358870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis.
    Zang DW; Yang Q; Wang HX; Egan G; Lopes EC; Cheema SS
    Eur J Neurosci; 2004 Oct; 20(7):1745-51. PubMed ID: 15379995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.